Page 94 - Sitomegalovirüs Tanı, Tedavi Uzlaşı Raporu

KAYNAKLAR

1. Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The
Third International Consensus Guidelines on the Management of Cytomegalovirus in
Solid-organ Transplantation. Transplantation. 2018;102(6):900-31.
2. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al.
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in
Clinical Trials: Table 1. Snydman DR, editor. Clin Infect Dis. 2017;64(1):87–91.
3. Crumpacker CS. Cytomegalovirus (CMV). Mand Douglas, Bennett’s Princ Pract Infect
Dis. Content Repository Only!; 2015;1738-1753.e4.
4. Society BT. Guidelines for the prevention and management of cytomegalovirus
disease after solid organ transplantation. Br Transplant Soc. 2015;(July).
https://bts.org.uk/wp-content/uploads/2016/09/14_BTS_CMV_3RDE-1.pdf (Erişim
tarihi: 02.09.2019)
5. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-
Guidelines of the American Society of Transplantation Infectious Diseases
Community of Practice. Clin Transplant. 2019;33(9):e13512.
6. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and
demographic characteristics associated with infection. Rev Med Virol. 2010;20:202-
13.
7. Alacam R. A study on the prevalence of cytomegalovirus complement-fixing
antibodies in the Turkish population. Mikrobiyol Bul. 1980;14:47-52.
8. Ataman S, Colak D, Günseren F, Senol Y, Colak T, Aktekin MR, Gültekin M.
Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based
cross-sectional study and review of related data in Turkey. Mikrobiyol Bul.
2007;41:545-55.
9. Satilmiş A, Güra A, Ongun H, Mendilcioğlu I, Colak D, Oygür N. CMV seroconversion
in pregnants and the incidence of congenital CMV infection. Turk J Pediatr.
2007;49(1):30-6.
10. Uysal A, Taner CE, Cüce M, Atalay S, Göl B, Köse S, Uysal F. Cytomegalovirus and
rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of
pregnancy outcome. Arch Gynecol Obstet. 2012;286(3):605-8.
11. Parlak M, Çim N, Nalça Erdin B, Güven A, Bayram Y, Yıldızhan R. Seroprevalence of
Toxoplasma, Rubella, and Cytomegalovirus among pregnant women in Van. Turk J
Obstet Gynecol. 2015;12(2):79-82.
12. Fishman JA. Overview: cytomegalovirus and the herpesviruses in transplantation. Am
J Transplant. 2013;13 (Suppl 3):1-8; quiz 8.
13. Razonable RR, Pang XL. Clinical Utility of Viral Load in Management of
Cytomegalovirus Infection after Solid Organ Transplantation. Clinical Microbiology
Reviews 2013;26:703-727.
14. Ramanan P, Razonable RR. Cytomegalovirus Infections in Solid Organ
Transplantation: A Review. Infect Chemother. 2013;45(3):260-271.
15. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global
burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102.
16. Mussi-Pinhata MM, Yamamoto AY, Britto MMM. Birth prevalence and natural history
of congenital cytomegalovirus (CMV) infection in a highly seroimmune population.
Clin Infect Dis 2009;49:522-8.

91